Syngene International (NSE:SYNGENE) Cash Flow for Dividends: ₹0 Mil (TTM As of Mar. 2026)


NSE:SYNGENE Syngene International Ltd NSE:SYNGENE
79 GF Score
Price ₹420.35
GF Value ₹768.96
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Syngene International Cash Flow for Dividends?

Syngene International NSE:SYNGENE +1.19% 79 Cash Flow for Dividends is ₹0 Mil as of Mar. 2026. GuruFocus rates NSE:SYNGENE with a GF Score™ of 79/100 and a GF Value™ of ₹768.96 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Syngene International's cash flow for dividends for the three months ended in Mar. 2026 was ₹0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Syngene International's annual payment of dividends stayed the same from Mar. 2024 (₹-503 Mil) to Mar. 2025 (₹-503 Mil) but then increased from Mar. 2025 (₹-503 Mil) to Mar. 2026 (₹-504 Mil).

Syngene International Cash Flow for Dividends Related Terms

Syngene International Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Syngene International's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Syngene International Cash Flow for Dividends Chart

Syngene International Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -401.00 -503.00 -503.00 -504.00

Syngene International Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:SYNGENE
79GF Score
Syngene International Ltd NSE:SYNGENE
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Syngene International Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of ₹0 Mil mean?
Syngene International (NSE:SYNGENE) has a Cash Flow for Dividends of ₹0 Mil as of Mar. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Syngene International and its competitors.
Is Syngene International's Cash Flow for Dividends too high?
Syngene International's current Cash Flow for Dividends is ₹0 Mil. Overall, Syngene International has a GF Score™ of 79/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Syngene International's Cash Flow for Dividends compare to TMO and DHR?
Syngene International's Cash Flow for Dividends of ₹0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Medical Diagnostics & Research company?
A good Cash Flow for Dividends depends on the Medical Diagnostics & Research industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Syngene International and its competitors. Syngene International's current Cash Flow for Dividends is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Syngene International stock overvalued right now?
Based on GuruFocus' analysis, Syngene International (NSE:SYNGENE) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹768.96, compared to a current price of ₹420.35 — trading 45.3% below its estimated fair value. The current Cash Flow for Dividends is ₹0 Mil. Syngene International's overall GF Score™ is 79/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Syngene International (NSE:SYNGENE), the current Cash Flow for Dividends is ₹0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Syngene International (NSE:SYNGENE) Overvalued in 2026?

Based on GuruFocus' analysis, Syngene International stock appears to be undervalued. The current stock price of ₹420.35 is trading 45.3% below its estimated GF Value™ of ₹768.96. GuruFocus considers Syngene International to be Significantly Undervalued.

Key valuation signals for NSE:SYNGENE:

  • Cash Flow for Dividends: ₹0 Mil
  • GF Value™: ₹768.96 vs. price of ₹420.35 (45.3% below fair value)
  • GF Score™: 79/100 with 3 warning signs

No single metric tells the full story. See the NSE:SYNGENE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Syngene International Business Description

Other Exchanges 539268:India
Address Jigani Link Road, Biocon SEZ, Biocon Park, Plot No. 2 and 3, IV Phase, Bommasandra Industrial Area, Bangalore, KA, IND, 560 099
Syngene International Ltd is a contract research and manufacturing organization in India. It supports research and development programs, from lead generation to clinical and commercial supplies. The Company is engaged in a single operating segment of providing contract research and manufacturing services. The company operates in India, the United States of America and other countries, of which a majority of the revenue is derived from the USA. The company receives revenue by providing contract research and manufacturing services. It offers services such as Oligonucleotide synthesis, Bioinformatics, Clinical development services, polymer research, chemical development, safety assessment, discovery chemistry, discovery biology, and others.
79GF Score

Get the complete analysis for NSE:SYNGENE

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹420.35
Price
₹768.96
GF Value